A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Peplin
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Inclusion
Patient has provided informed consent documented by signing the Informed Consent Form (ICF) prior to any study-related procedures
Patient achieved complete clearance of AK lesions (lesion count of 0) in the selected treatment area at the Day 57 visit in the following Peplin AK clinical Study: PEP005-028
Exclusion
Concurrent participation in another research study which would involve the selected treatment area (except for any post-study follow-up visits for previous Peplin AK study)
Early termination from study PEP005-028
Clareo Health | A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
